Statins and Cerebral Blood Flow in Subarachnoid Hemorrhage (SAH)
Recruiting
Phase 1/2 Results N/ASummary of Purpose
The primary objective of this project is to investigate the effect of statin therapy on cerebral blood flow in patients with aneurysmal SAH who are randomized to receive or not receive statins in a blinded design.
Read More →Trial Milestones
The following dates are available for this trial. Trial information last updated on 2 March 2011.
| 1 Aug 2008 | 20 Nov 2008 | 1 Feb 2013 | 1 Mar 2013 | 1 Mar 2011 | Unavailable |
| Start Date | First Received | 1st Completion | Completion | Verification | Results |
|---|
Trial Basics
Interventions
Conditions
Sponsors
Trial Design
- Allocation: Randomized
- Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
- Purpose: Treatment
- Endpoint: Efficacy Study
- Intervention: Parallel Assignment
Contacts
- Abbie Bradley, RN
bradleya@nsurg.wustl.edu (314) 747-8882
View Trial Locations
Recruitment
- Enrollment: 60
- Gender: Both
- Minimum Age: 18 Years
- Accepts Healthy Volunteers: No
- 1 location, 1 country
Principal Investigator
- Michael Diringer, MD
Washington University School of Medicine
